In summary, anti-VCAM1 and anti-IL4Rα aptamers specific to VCAM-1 and IL4Rα receptors biomarkers that are overexpressed in 4T1-Luc2 tumor bearing mice were used as diagnostic and therapeutic tools for breast cancer. Here, IL4R is linked to breast carcinoma.